69th Annual Heber W. Youngken, Jr. “Last Chance” Pharmacy Clinic
Thursday, November 5th, 2026 | Zoom Opens at 8:15 AM | Program: 8:30AM – 2:45PM
Register – $89Overview
Women’s healthcare is evolving rapidly, and pharmacists are playing an increasingly important role in improving access, counseling patients, and optimizing outcomes. Join colleagues for the 69th Annual Heber W. Youngken, Jr. “Last Chance” Pharmacy Clinic for a timely day of continuing education exploring the latest evidence and innovations in women’s health across the lifespan. National experts will provide practical updates on menopause management, hormone and non-hormonal therapies, GLP-1 medications beyond weight loss, metabolic health, reproductive health, preventive care through immunization, and Rhode Island pharmacy law. Through evidence-based presentations and patient cases, participants will gain practical strategies they can immediately apply to strengthen patient care in a variety of practice settings. The clinic provides 5.0 live contact hours (0.5 CEUs) of continuing pharmacy education credit for pharmacists, including 1 hour of immunization CE and 1 hour of pharmacy law CE.
Zoom Events Information
A computer or mobile device with an internet connection and access to Zoom is required to participate in this live webinar.
All registrants will receive Zoom access instructions by email directly from Zoom Events email address: noreply-zoomevents@zoom.us. This email will be sent to your registration email address the Monday before the conference.
Target Audience
Pharmacists in all practice settings.
Agenda & Learning Objectives
*Subject to minor timing changes between now and the event
| 8:30AM | Welcome and Introductions Mary-Jane Kanaczet, MEd, CHCP |
| 8:45AM | Transforming Women’s Health: Emerging Challenges, New Opportunities, and the Pharmacist’s Role |
|---|---|
| Speaker | Kathleen Hill-Besinque, PharmD, MSEd, FASHP, FCSHP, FCPhA, MSCP |
| Upon completion of this educational activity, pharmacists will be able to: – Describe key trends and unmet needs affecting women’s health across the lifespan. – Discuss the evolving role of pharmacists in improving access to evidence-based women’s healthcare services. – Identify emerging therapeutic, public health, and practice advancement opportunities impacting women’s health. – Recognize strategies pharmacists can implement to improve health outcomes and patient engagement in women’s healthcare. | |
| Knowledge-based, 1.0 hr. (0.1 CEU) | UAN: 0060-0000-26-044-L01-P |
| 9:45AM | Women’s Health Across the Lifespan: Prevention, Immunization, and the Pharmacist’s Role (Immunization CE) |
|---|---|
| Speaker | Veronica Vernon, PharmD, BCPS, BCACP, MSCP, FAPh |
| Upon completion of this educational activity, pharmacists will be able to: – Review evidence-based preventive health recommendations relevant to women across the lifespan, including cancer screening, cardiovascular risk reduction, and osteoporosis prevention. – Describe current immunization recommendations for women during reproductive years, pregnancy, midlife, and older adulthood. – Identify opportunities for pharmacists to improve access to preventive services through vaccination, screening referrals, and medication optimization. – Apply patient-centered counseling strategies to address vaccine hesitancy and common misconceptions related to women’s preventive health. | |
| Application-based, 1.0 hr. (0.1 CEU) | UAN: 0060-0000-26-047-L06-P |
| 10:45AM | Break |
| 11:00AM | Menopause Management in Clinical Practice: Hormones, Regulatory Considerations, Emerging Therapies, and Patient Cases (Law CE) |
|---|---|
| Speaker | Paris Dade, PharmD |
| Upon completion of this educational activity, pharmacists will be able to: – Review current guideline recommendations for the management of vasomotor symptoms, genitourinary syndrome of menopause, and other common menopause-related concerns. – Compare hormonal and nonhormonal treatment options, including recently approved and emerging therapies for menopause symptom management. – Discuss legal and regulatory considerations to menopause therapies that influence pharmacy practice and patient care. – Evaluate patient-specific factors that influence treatment selection, safety, and monitoring of menopause therapies. – Apply evidence-based treatment strategies through case-based discussions commonly encountered in menopause practice. | |
| Application-based, 1.0 hr. (0.1 CEU) | UAN: 0060-0000-26-046-L03-P |
| 12:00PM | Dean’s Welcome and Announcement of Scholarships – Virtual Lunch Break Kerry LaPlante, PharmD, FCCP, FIDSA, FIDP Dean, College of Pharmacy, The University of Rhode Island |
| 12:30PM | Beyond Weight Loss: GLP-1s, Metabolic Health, and Emerging Therapies in Pharmacy Practice |
|---|---|
| Speaker | Jennifer Newell Leavitt, PharmD, CDCES, CDOE, CVDOE |
| Upon completion of this educational activity, pharmacists will be able to: – Describe physiologic and metabolic changes that contribute to obesity, insulin resistance, and cardiometabolic disease across midlife and aging populations. – Review current evidence supporting GLP-1–based therapies and emerging pharmacologic approaches for obesity and metabolic disease management. – Develop patient-centered counseling and monitoring strategies for individuals receiving GLP-1 therapies, including management of adverse effects, adherence, and common misconceptions. – Discuss emerging therapies for MASH and their implications for pharmacists. | |
| Application-based, 1.0 hr. (0.1 CEU) | UAN: 0060-0000-26-045-L01-P |
| 1:30PM | Women’s Health OTC Pearls: Separating the Evidence from the Hype |
|---|---|
| Speaker | Oluwatobi Akinsanya, PharmD |
| Upon completion of this educational activity, pharmacists will be able to: – Describe current evidence and guideline recommendations for over-the-counter therapies for menopause. – Identify effective patient counseling strategies and situations that warrant referral to an appropriate healthcare professional. | |
| Knowledge-based, 0.5 hr. (0.05 CEU) | UAN: 0060-0000-26-048-L01-P |
| 2:00PM | Advances in Endometriosis Management: A Pharmacotherapy Update |
|---|---|
| Speaker | Zumar Smith, PharmD |
| Upon completion of this educational activity, pharmacists will be able to: -Review current evidence and guideline recommendations for the pharmacologic management of endometriosis. – Individualize treatment recommendations based on symptom severity, reproductive goals, comorbidities, and medication safety considerations. | |
| Application-based, 0.5 hr. (0.05 CEU) | UAN: 0060-0000-26-049-L01-P |
| 2:30PM | Program Summary and Evaluation Instructions Mary-Jane Kanaczet, MEd, CHCP |
| 2:45PM | Adjourn |
Speakers
Requirements for Credit
A program evaluation must be completed at www.uripharmacycpd.org within 60 days of the live program date in order to receive CE credit. CE credit will be transferred to the CPE Monitor upon successful completion of the program evaluation. Transfer of CE credit should be verified at mycpemonitor.net where CE statements are available to print. Please refer to the evaluation instructions that follow for completing program evaluations and reporting CE credit.
Evaluation
All participants will have the opportunity to review the educational sessions and speakers and to identify future educational needs.
Registration
Registration for this program is $89
- Login or create an account in URI’s learning management and CE reporting system using your email address and professional license number. Complete all required account set up fields to ensure accurate CE reporting.
- Select “Available Live Activities”
- Choose “69th Annual Heber W. Youngken, Jr. Last Chance Pharmacy Clinic”
- Select “Add to Cart” to checkout, and proceed to secure online payment (Visa, MC, AMEX, Discover or Electronic Checks accepted)
Refund Policy: Registration fees, subject to a $15 processing fee, will be refunded provided that a notification email is sent to pharmce@etal.uri.edu at least seven (7) days prior to the program start date.
Statement of Disclosure
In accordance with the Accreditation Council for Pharmacy Education (ACPE) Standards for Continuing Pharmacy Education, The University of Rhode Island College of Pharmacy requires that program faculty disclose any relationship (e.g., shareholder, recipient of research grant, consultant or member of an advisory committee) that the faculty may have with ineligible companies whose products or services may be mentioned in their presentations. No one involved in the planning of this program has any relevant financial relationships to disclose.